184 related articles for article (PubMed ID: 2847994)
1. Efficacy of tetrahydrocannabinol in patients refractory to standard antiemetic therapy.
McCabe M; Smith FP; Macdonald JS; Woolley PV; Goldberg D; Schein PS
Invest New Drugs; 1988 Sep; 6(3):243-6. PubMed ID: 2847994
[TBL] [Abstract][Full Text] [Related]
2. Randomized, double-blind comparison of a prochlorperazine-based versus a metoclopramide-based antiemetic regimen in patients undergoing autologous bone marrow transplantation.
Gilbert CJ; Ohly KV; Rosner G; Peters WP
Cancer; 1995 Dec; 76(11):2330-7. PubMed ID: 8635039
[TBL] [Abstract][Full Text] [Related]
3. Delta-9-tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy. A comparison with prochlorperazine and a placebo.
Frytak S; Moertel CG; O'Fallon JR; Rubin J; Creagan ET; O'Connell MJ; Schutt AJ; Schwartau NW
Ann Intern Med; 1979 Dec; 91(6):825-30. PubMed ID: 517882
[TBL] [Abstract][Full Text] [Related]
4. Antiemetic effect of tetrahydrocannabinol. Compared with placebo and prochlorperazine in chemotherapy-associated nausea and emesis.
Orr LE; McKernan JF; Bloome B
Arch Intern Med; 1980 Nov; 140(11):1431-3. PubMed ID: 6254456
[TBL] [Abstract][Full Text] [Related]
5. Antiemetics in patients receiving chemotherapy for cancer: a randomized comparison of delta-9-tetrahydrocannabinol and prochlorperazine.
Sallan SE; Cronin C; Zelen M; Zinberg NE
N Engl J Med; 1980 Jan; 302(3):135-8. PubMed ID: 6985702
[TBL] [Abstract][Full Text] [Related]
6. Antiemetic effect of delta 9-tetrahydrocannabinol in chemotherapy-associated nausea and emesis as compared to placebo and compazine.
Orr LE; McKernan JF
J Clin Pharmacol; 1981; 21(S1):76S-80S. PubMed ID: 6271846
[TBL] [Abstract][Full Text] [Related]
7. Nabilone: an effective antiemetic agent in patients receiving cancer chemotherapy.
Einhorn L
Cancer Treat Rev; 1982 Dec; 9 Suppl B():55-61. PubMed ID: 6299557
[No Abstract] [Full Text] [Related]
8. Improved control of high-dose-cisplatin-induced acute emesis with the addition of prochlorperazine to granisetron/dexamethasone.
Hesketh PJ; Gandara DR; Hesketh AM; Edelman M; Webber LM; McManus M; Hainsworth JD
Cancer J Sci Am; 1997; 3(3):180-3. PubMed ID: 9161784
[TBL] [Abstract][Full Text] [Related]
9. Amelioration of cancer chemotherapy-induced nausea and vomiting by delta-9-tetrahydrocannabinol.
Ekert H; Waters KD; Jurk IH; Mobilia J; Loughnan P
Med J Aust; 1979 Dec; 2(12):657-9. PubMed ID: 231736
[TBL] [Abstract][Full Text] [Related]
10. A double-blind, controlled trial of nabilone vs. prochlorperazine for refractory emesis induced by cancer chemotherapy.
Johansson R; Kilkku P; Groenroos M
Cancer Treat Rev; 1982 Dec; 9 Suppl B():25-33. PubMed ID: 6299551
[No Abstract] [Full Text] [Related]
11. Delata-9-tetrahydrocannabinol as an antiemetic in cancer patients receiving high-dose methotrexate. A prospective, randomized evaluation.
Chang AE; Shiling DJ; Stillman RC; Goldberg NH; Seipp CA; Barofsky I; Simon RM; Rosenberg SA
Ann Intern Med; 1979 Dec; 91(6):819-24. PubMed ID: 293141
[TBL] [Abstract][Full Text] [Related]
12. delta 9-Tetrahydrocannabinol for refractory vomiting induced by cancer chemotherapy.
Lucas VS; Laszlo J
JAMA; 1980 Mar; 243(12):1241-3. PubMed ID: 6244418
[TBL] [Abstract][Full Text] [Related]
13. Nabilone: an effective antiemetic in patients receiving cancer chemotherapy.
Einhorn LH; Nagy C; Furnas B; Williams SD
J Clin Pharmacol; 1981; 21(S1):64S-69S. PubMed ID: 6271844
[TBL] [Abstract][Full Text] [Related]
14. Dronabinol and prochlorperazine in combination for treatment of cancer chemotherapy-induced nausea and vomiting.
Lane M; Vogel CL; Ferguson J; Krasnow S; Saiers JL; Hamm J; Salva K; Wiernik PH; Holroyde CP; Hammill S
J Pain Symptom Manage; 1991 Aug; 6(6):352-9. PubMed ID: 1652611
[TBL] [Abstract][Full Text] [Related]
15. Dronabinol and prochlorperazine alone and in combination as antiemetic agents for cancer chemotherapy.
Lane M; Smith FE; Sullivan RA; Plasse TF
Am J Clin Oncol; 1990 Dec; 13(6):480-4. PubMed ID: 2173391
[TBL] [Abstract][Full Text] [Related]
16. A prospective evaluation of delta-9-tetrahydrocannabinol as an antiemetic in patients receiving adriamycin and cytoxan chemotherapy.
Chang AE; Shiling DJ; Stillman RC; Goldberg NH; Seipp CA; Barofsky I; Rosenberg SA
Cancer; 1981 Apr; 47(7):1746-51. PubMed ID: 6261926
[TBL] [Abstract][Full Text] [Related]
17. Antiemetic efficacy of dexamethasone. Randomized, double-blind, crossover study with prochlorperazine in patients receiving cancer chemotherapy.
Markman M; Sheidler V; Ettinger DS; Quaskey SA; Mellits ED
N Engl J Med; 1984 Aug; 311(9):549-52. PubMed ID: 6379459
[TBL] [Abstract][Full Text] [Related]
18. Continuous infusion prochlorperazine: pharmacokinetics, antiemetic efficacy, and feasibility of high-dose therapy.
Morgan RJ; Synold T; Carr BI; Doroshow JH; Womack EP; Shibata S; Somlo G; Raschko J; Leong L; McNamara M; Chow W; Tetef M; Margolin K; Akman S; Longmate J
Cancer Chemother Pharmacol; 2001 Apr; 47(4):327-32. PubMed ID: 11345649
[TBL] [Abstract][Full Text] [Related]
19. A randomized trial of oral nabilone and prochlorperazine compared to intravenous metoclopramide and dexamethasone in the treatment of nausea and vomiting induced by chemotherapy regimens containing cisplatin or cisplatin analogues.
Cunningham D; Bradley CJ; Forrest GJ; Hutcheon AW; Adams L; Sneddon M; Harding M; Kerr DJ; Soukop M; Kaye SB
Eur J Cancer Clin Oncol; 1988 Apr; 24(4):685-9. PubMed ID: 2838294
[TBL] [Abstract][Full Text] [Related]
20. delta 9-tetrahydrocannabinol in clinical oncology.
Poster DS; Penta JS; Bruno S; Macdonald JS
JAMA; 1981 May 22-29; 245(20):2047-51. PubMed ID: 6262541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
